Faculty Directory

Jack Chen, PharmD
Associate Professor, Pharmacotherapy and Outcomes Science School of Pharmacy
Associate Professor, Neurology School of Medicine

Research & Grantsmanship Funded Research Project (PI)

$25,000. Research grant. “Literature Analysis of Tetrabenazine for the Management of Huntignton’s Chorea and other Hyperkinetic Movement Disorders.” Lundbeck.

( 10/2009 - 10/2012 )

A retrospective evaluation of quetiapine for Huntingtons chorea ( 7/2005 - 6/2006 )

Funded Research Project (CI)

Systematic Review of AbobotulinumtoxinA for movement disorders
( 1/2012 - 1/2013 )

Co-Investigator. Serotonin Toxcity Assocation with ConComitant AnTidepressant and Rasagiline Treatment: RetrOspective Chart Review (STACCATO). Teva TVP 1012/PM102.

( 10/2009 - 10/2010 )

A long-term, multicenter, open-label safety study with oral 20 or 40 mg/d doses of KW-6002 (istradefylline) as treatment of Parkinson's disease in patients with motor response complications on levodopa therapy. ( 7/2005 - 6/2006 )

A randomized double blind study of oral thiamine in the treatment of painful diabetic peripheral neuropathy. ( 7/2005 - 6/2006 )

A multicenter, double-blind, randomized start, placebo-controlled, parallel-group study to assess rasagiline as a disease modifying therapy in early Parkinson?s disease subjects. ( 7/2005 - 6/2006 )

A clinical evaluation of bilateral stimulation of the subthalamic nucleus (STN) using the ANS Totally Implantable Deep Brain Stimulation System as an adjunctive treatment for reducing some of the symptoms of advanced, levodopa-responsive Parkinson?s disease that are not adequately controlled with medication. ( 7/2005 - 6/2006 )

A clinical evaluation of the ANS Totally Implantable Deep Brain Stimulation System for the suppression of tremor in the upper extremities of patients with essential tremor. ( 7/2005 - 6/2006 )

A multi-center, randomized, double-blind, placebo-controlled, parallel group study of the efficacy, safety, and tolerability of E2007 in levodopa treated Parkinson?s disease patients with motor fluctuations. ( 7/2005 - 6/2006 )

Grant Proposals--Funded

$25,000. Research grant. “Literature Analysis of Tetrabenazine for the Management of Huntignton’s Chorea and other Hyperkinetic Movement Disorders.” Lundbeck.

( 10/2009 - 10/2012 )

Grant Proposals--Submitted

Zonegran for Essential Tremor
( 10/2009 )

Abstracts Reporting Research -- Peer Reviewed

Chen JJ, Trosch RM, Comella CL, Lew MF, LeWitt PA, Singer C, Russel S, Chang S, Clary CM, Silay Y, Coleman CM, Marchese D, Hubble JP. ANCHOR-CD (AbobotulinumtoxinA Neurotoxin: Clinical and Health Economics Outcomes Registry in Cervical Dystonia): A Multicenter, Observational Study of Dysport in Cervical Dystonia: Baseline Data and Cycle One Outcomes Data. J Pharm Pract 2012;25:261-262.

( 4/2012 )

Chen JJ, Trosch RM, Comella CL, Lew MF, LeWitt PA, Singer C, Marchese D, Russel S, Chang S, Clary C, Silay Y, Coleman CM, Hubble JP. ANCHOR-CD (AbobotulinumtoxinA Neurotoxin: Clinical and Health Economics Outcomes Registry in Cervical Dystonia): A Multicenter, Observational Study of Dysport in Cervical Dystonia: Patient Demographic, History, and Health Economics Data. J Pharm Pract 2012;25:262.

( 3/2012 )

Panisett M, Chen JJ, Rhyee SH. Assessing the occurrence of serotonin toxicity in Parkinson’s disease patients receiving rasagiline and antidepressants. Neurology 2011;76(suppl4):A539.

( 4/2011 )

Dashtipour K, Wright SW, Barber A, Ghamsary M, Chen JJ, Pezeshkian S, Swope D, Demattos N. Different clinical phenotype of Parkinson’s disease in patients with and without REM behavior disturbances. Neurology 2011;76(suppl4):A493.

( 3/2011 )

Chen JJ, Prideaux M, Swope DM. Open-label naturalistic study of pregabalin for cervical dystonia and other hyperkinetic movement disorders (HMDs): effectiveness and tolerability. Pharmacotherapy 2009;29:221e-222e.

( 10/2009 )

Swope DM, Chen JJ, Sadiqua N. Adult onset focal truncal dystonia and improvement with botulinum toxin A. Mov Disord 2008;23(suppl 1):S177.

( 10/2008 )

Chen JJ, Swope DM, Gascon RS.. "Zonisamide for the treatment of essential tremor: a case study." Pharmacotherapy 25. (2005): 1466-1466. ( 10/2005 )

Chen JJ, Swope DM, Nist L.. "Botulinum toxin for cervical dystonia in myasthenia gravis: a case study." Pharmacotherapy 25. (2005): 1466-1466. ( 10/2005 )

Chen JJ, Berchou RC. . "Low incidence of cognitive and behavioral adverse events in rasagiline-treated patients with early to advanced Parkinson?s disease." Pharmacotherapy 25. (2005): 1466-1466. ( 10/2005 )

Chen JJ, Berchou RC. . ". Rasagiline is effective as monotherapy in patients with early Parkinson?s disease and as adjunctive therapy in moderate to advanced PD." Pharmacotherapy 25. (2005): 1466-1467. ( 10/2005 )

Berchou RC, Chen JJ.. "Rasagiline provides significant management of motor symptoms in early and moderate-to-advanced Parkinson?s disease." Pharmacotherapy 25. (2005): 1467-1467. ( 10/2005 )

Chen JJ.. "Pharmacuetica philatelica in recognition of American pharmacy." J Am Pharm Assoc 45. (2005): 2901-291. ( 7/2005 )

Chen JJ, Swope DM, Gascon RS. "Zonisamide for the treatment of essential tremor: a case study.." Pharmacotherapy 25. (2005): 1466-1466. ( 1/2005 )